Evotec SE (EVO) Free Cash Flow Growth (1y) (2022 - 2026)
Evotec SE (EVO) Free Cash Flow Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 10.34% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -43.16% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.44% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 152.68% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 44.93% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -291.47% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 49.78% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 24.53% |
| 10 | Evotec SE | 570.60 Mn | 570.08 Mn | - | 102.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102.02% |
| Dec 31, 2025 | 10.36% |
| Sep 30, 2025 | -172.65% |
| Jun 30, 2025 | 418.74% |
| Mar 31, 2025 | -65.97% |
| Dec 31, 2024 | 44.30% |
| Sep 30, 2024 | 2.94% |
| Jun 30, 2024 | -110.64% |
| Mar 31, 2024 | 81.08% |
| Dec 31, 2023 | -865.92% |
| Sep 30, 2023 | 130.26% |
| Jun 30, 2023 | -33.24% |
| Mar 31, 2023 | -138.13% |
| Dec 31, 2022 | 182.56% |
| Sep 30, 2022 | -2,943.90% |
| Jun 30, 2022 | 705.88% |
| Mar 31, 2022 | 255,676.65% |